TERSUS LIFE SCIENCES, LLC
ESTERO, FLORIDA

Tersus Life Sciences, LLC is an innovative biopharmaceutical company nestled in Bonita Springs, Florida. The company came to life with support from grants under the Affordable Care Act, channeling funding into groundbreaking biomedical research. At their core, Tersus focuses on revolutionizing cardiovascular health and tackling metabolic syndrome through its flagship product, Provinal™. This ultrapurified Omega 7 fatty acid blend is specially designed to address critical conditions like Metabolic Syndrome, Insulin resistance, and Diabetes. The scientific journey at Tersus is spearheaded by Dr. Tina Sampalis, M.D., Ph.D., their Chief Scientific Officer. With an impressive background as an Oncology Surgeon and expertise in fields ranging from Physiology to Experimental Surgery, she brings a wealth of knowledge to the company's R&D efforts. Adding to the brilliance of the team is Dr. Michael Roizen, known widely for his work at the Cleveland Clinic and serving on Tersus's Scientific Advisory Board. Pioneering in the commercialization of Omega 7 fatty acids, Tersus holds multiple patents with many more pending registration. Their patented processes significantly reduce harmful palmitic acid content, making their product uniquely beneficial. A key component of Tersus's mission is to establish and maintain a sustainable supply chain capable of meeting global demand for Provinal®. As a company firmly based in Florida since March 24, 2017, Tersus operates out of their headquarters at 8000 Health Center Blvd., Bonita Springs. They welcome inquiries via official channels or direct phone contacts. The strategic direction is further enriched by the expertise of key board members like OPS Executive Connie Dease.